☰

Hai-Ling M. Cheng, Ph.D. - Publications

Affiliations: 
2003 University of Toronto, Toronto, ON, Canada 
Area:
Medical Biophysics
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Szulc DA, Lee XA, Cheng HM, Cheng HM. Bright Ferritin-a Reporter Gene Platform for On-Demand, Longitudinal Cell Tracking on MRI. Iscience. 23: 101350. PMID 32707432 DOI: 10.1016/J.Isci.2020.101350  0.343
2020 Zakher E, Ganesh T, Cheng HM. A novel MRI analysis for assessment of microvascular vasomodulation in low-perfusion skeletal muscle. Scientific Reports. 10: 4705. PMID 32170106 DOI: 10.1038/S41598-020-61682-Z  0.365
2019 Szulc DA, Ahmadipour M, Aoki FG, Waddell TK, Karoubi G, Cheng HM. MRI method for labeling and imaging decellularized extracellular matrix scaffolds for tissue engineering. Magnetic Resonance in Medicine. PMID 31729091 DOI: 10.1002/Mrm.28072  0.311
2019 Haedicke IE, Loai S, Cheng HM. An Efficient Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI. Contrast Media & Molecular Imaging. 2019: 3475786. PMID 31316306 DOI: 10.1155/2019/3475786  0.386
2019 Szulc DA, Cheng HM. One-Step Labeling of Collagen Hydrogels with Polydopamine and Manganese Porphyrin for Non-Invasive Scaffold Tracking on Magnetic Resonance Imaging. Macromolecular Bioscience. e1800330. PMID 30645045 DOI: 10.1002/Mabi.201800330  0.367
2018 Venter A, Szulc DA, Loai S, Ganesh T, Haedicke IE, Cheng HM. A manganese porphyrin-based T1 contrast agent for cellular MR imaging of human embryonic stem cells. Scientific Reports. 8: 12129. PMID 30108285 DOI: 10.1038/S41598-018-30661-W  0.372
2018 Alhamami M, Cheng W, Lyu Y, Allen C, Zhang XA, Cheng HM. Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer. Plos One. 13: e0196998. PMID 29795583 DOI: 10.1371/Journal.Pone.0196998  0.341
2017 Alvares RDA, Szulc DA, Cheng HM. A scale to measure MRI contrast agent sensitivity. Scientific Reports. 7: 15493. PMID 29138455 DOI: 10.1038/S41598-017-15732-8  0.341
2016 Haedicke IE, Li T, Zhu YLK, Martinez F, Hamilton AM, Murrell DH, Nofiele JT, Cheng HM, Scholl TJ, Foster PJ, Zhang XA. An enzyme-activatable and cell-permeable Mn-porphyrin as a highly efficient MRI contrast agent for cell labeling. Chemical Science. 7: 4308-4317. PMID 30155077 DOI: 10.1039/C5Sc04252F  0.373
2016 Loai S, Haedicke I, Mirzaei Z, Simmons CA, Zhang XA, Cheng HM. Positive-contrast cellular MRI of embryonic stem cells for tissue regeneration using a highly efficient T1 MRI contrast agent. Journal of Magnetic Resonance Imaging : Jmri. PMID 27185221 DOI: 10.1002/Jmri.25299  0.372
2014 Mokhtari RB, Nofiele JT, Islam SS, Yeger H, Cheng HM. Abstract 1220: Investigation of the biological properties of human breast cancer in a nude rat model Cancer Research. 74: 1220-1220. DOI: 10.1158/1538-7445.Am2014-1220  0.302
2012 Loai Y, Ganesh T, Cheng HM. Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles. International Journal of Molecular Imaging. 2012: 230942-230942. PMID 22919479 DOI: 10.1155/2012/230942  0.331
2012 Cheng HM, Loai Y, Farhat WA. Monitoring tissue development in acellular matrix-based regeneration for bladder tissue engineering: multiexponential diffusion and T2* for improved specificity. Nmr in Biomedicine. 25: 418-426. PMID 22351641 DOI: 10.1002/Nbm.1617  0.349
2011 Kershaw LE, Cheng HM. A general dual-bolus approach for quantitative DCE-MRI. Magnetic Resonance Imaging. 29: 160-166. PMID 21129878 DOI: 10.1016/J.Mri.2010.08.009  0.358
2010 Kershaw LE, Cheng HM. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model Magnetic Resonance in Medicine. 64: 1772-1780. PMID 20715059 DOI: 10.1002/Mrm.22573  0.311
2009 Cheng HM. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach. Journal of Magnetic Resonance Imaging. 30: 864-872. PMID 19787732 DOI: 10.1002/Jmri.21916  0.35
2007 Cheng HM. Dynamic contrast-enhanced MRI in oncology drug development. Current Clinical Pharmacology. 2: 111-122. PMID 18690858 DOI: 10.2174/157488407780598180  0.355
2007 Cheng HM. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. Journal of Magnetic Resonance Imaging. 25: 1073-1078. PMID 17410576 DOI: 10.1002/Jmri.20898  0.32
Show low-probability matches.